Literature DB >> 27755267

Helicobacter bilis Infection Alters Mucosal Bacteria and Modulates Colitis Development in Defined Microbiota Mice.

Todd Atherly1, Curtis Mosher, Chong Wang, Jesse Hostetter, Alexandra Proctor, Meghan W Brand, Gregory J Phillips, Michael Wannemuehler, Albert E Jergens.   

Abstract

BACKGROUND: Helicobacter bilis infection of C3H/HeN mice harboring the altered Schaedler flora (ASF) triggers progressive immune responsiveness and the development of colitis. We sought to investigate temporal alterations in community structure of a defined (ASF-colonized) microbiota in normal and inflamed murine intestines and to correlate microbiota changes to histopathologic lesions.
METHODS: The colonic mucosal microbiota of healthy mice and ASF mice colonized with H. bilis for 3, 6, or 12 weeks were investigated by fluorescence in situ hybridization targeting the 16S ribosomal RNA genes of total bacteria, group-specific organisms, and individual ASF bacterial species. Microbial profiling of ASF and H. bilis abundance was performed on cecal contents.
RESULTS: Helicobacter bilis-colonized mice developed colitis associated with temporal changes in composition and spatial distribution of the mucosal microbiota. The number of total bacteria, ASF519, and helicobacter-positive bacteria were increased (P < 0.05), whereas ASF360/361-positive bacteria were decreased (P < 0.05) versus controls. Adherent biofilms in colitic mice were most often (P < 0.05) composed of total bacteria, ASF457, and H. bilis. Total numbers of ASF519 and H. bilis bacteria were positively correlated (P = 0.03, r = 0.39 and P < 0.0001, r = 0.73), and total numbers of ASF360/361 bacteria were negatively correlated (P = 0.003, r = -0.53) to histopathologic score. Differences in cecal abundance of ASF members were not observed.
CONCLUSIONS: Altered community structure with murine colitis is characterized by distinct ASF bacteria that interact with the colonic mucosa, by formation of an isolating interlaced layer, by attachment, or by invasion, and this interaction is differentially expressed over time.

Entities:  

Mesh:

Year:  2016        PMID: 27755267      PMCID: PMC5123692          DOI: 10.1097/MIB.0000000000000944

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  49 in total

1.  Patchy distribution of mucosal lesions in ileal Crohn's disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis.

Authors:  Nadia Vasquez; Irène Mangin; Patricia Lepage; Philippe Seksik; Jean-Paul Duong; Stéphanie Blum; Eduardo Schiffrin; Antonia Suau; Matthieu Allez; Gwenola Vernier; Xavier Tréton; Joël Doré; Philippe Marteau; Philippe Pochart
Journal:  Inflamm Bowel Dis       Date:  2007-06       Impact factor: 5.325

Review 2.  Unravelling the pathogenesis of inflammatory bowel disease.

Authors:  R J Xavier; D K Podolsky
Journal:  Nature       Date:  2007-07-26       Impact factor: 49.962

3.  Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease.

Authors:  J Boudeau; A L Glasser; E Masseret; B Joly; A Darfeuille-Michaud
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 4.  Gastrointestinal structure and function in germ-free or gnotobiotic animals.

Authors:  G R Thompson; P C Trexler
Journal:  Gut       Date:  1971-03       Impact factor: 23.059

5.  Induction of differential immune reactivity to members of the flora of gnotobiotic mice following colonization with Helicobacter bilis or Brachyspira hyodysenteriae.

Authors:  Albert E Jergens; Andrea Dorn; Jenny Wilson; Krystal Dingbaum; Abigail Henderson; Zhiping Liu; Jesse Hostetter; Richard B Evans; Michael J Wannemuehler
Journal:  Microbes Infect       Date:  2006-04-18       Impact factor: 2.700

6.  Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice.

Authors:  Lillian Maggio-Price; Donna Shows; Kim Waggie; Andrew Burich; Weiping Zeng; Sabine Escobar; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 7.  The Altered Schaedler Flora: Continued Applications of a Defined Murine Microbial Community.

Authors:  Meghan Wymore Brand; Michael J Wannemuehler; Gregory J Phillips; Alexandra Proctor; Anne-Marie Overstreet; Albert E Jergens; Roger P Orcutt; James G Fox
Journal:  ILAR J       Date:  2015

8.  Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.

Authors:  R K Sellon; S Tonkonogy; M Schultz; L A Dieleman; W Grenther; E Balish; D M Rennick; R B Sartor
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.

Authors:  Harry Sokol; Bénédicte Pigneur; Laurie Watterlot; Omar Lakhdari; Luis G Bermúdez-Humarán; Jean-Jacques Gratadoux; Sébastien Blugeon; Chantal Bridonneau; Jean-Pierre Furet; Gérard Corthier; Corinne Grangette; Nadia Vasquez; Philippe Pochart; Germain Trugnan; Ginette Thomas; Hervé M Blottière; Joël Doré; Philippe Marteau; Philippe Seksik; Philippe Langella
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

10.  16S rRNA gene pyrosequencing reveals bacterial dysbiosis in the duodenum of dogs with idiopathic inflammatory bowel disease.

Authors:  Jan S Suchodolski; Scot E Dowd; Vicky Wilke; Jörg M Steiner; Albert E Jergens
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

View more
  7 in total

1.  A real-time PCR assay for accurate quantification of the individual members of the Altered Schaedler Flora microbiota in gnotobiotic mice.

Authors:  João Carlos Gomes-Neto; Sara Mantz; Kyler Held; Rohita Sinha; Rafael R Segura Munoz; Robert Schmaltz; Andrew K Benson; Jens Walter; Amanda E Ramer-Tait
Journal:  J Microbiol Methods       Date:  2017-02-09       Impact factor: 2.363

2.  Utilizing Whole Fusobacterium Genomes To Identify, Correct, and Characterize Potential Virulence Protein Families.

Authors:  Ariana Umaña; Blake E Sanders; Christopher C Yoo; Michael A Casasanta; Barath Udayasuryan; Scott S Verbridge; Daniel J Slade
Journal:  J Bacteriol       Date:  2019-11-05       Impact factor: 3.490

Review 3.  The microbiome in inflammatory bowel diseases: from pathogenesis to therapy.

Authors:  Sheng Liu; Wenjing Zhao; Ping Lan; Xiangyu Mou
Journal:  Protein Cell       Date:  2020-06-29       Impact factor: 14.870

4.  Tumor necrosis factor ligand-related molecule 1A affects the intestinal mucosal barrier function by promoting Th9/interleukin-9 expression.

Authors:  Caihong Zhao; Dong Wang; Mengyao Wu; Yuxin Luo; Mingyue Yang; Jinbo Guo; Hong Zhang; Xiaolan Zhang
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

5.  Vertical transmission of attaching and invasive E. coli from the dam to neonatal mice predisposes to more severe colitis following exposure to a colitic insult later in life.

Authors:  Meghan Wymore Brand; Alexandra L Proctor; Jesse M Hostetter; Naihui Zhou; Iddo Friedberg; Albert E Jergens; Gregory J Phillips; Michael J Wannemuehler
Journal:  PLoS One       Date:  2022-04-05       Impact factor: 3.240

Review 6.  The Intestinal Microbiota May Be a Potential Theranostic Tool for Personalized Medicine.

Authors:  Marina Di Domenico; Andrea Ballini; Mariarosaria Boccellino; Salvatore Scacco; Roberto Lovero; Ioannis Alexandros Charitos; Luigi Santacroce
Journal:  J Pers Med       Date:  2022-03-24

Review 7.  Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease by Inducing Host Immune Disorders.

Authors:  Wei Peng; Xinhua Zhao; Xiaoan Li
Journal:  Biomed Res Int       Date:  2022-08-09       Impact factor: 3.246

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.